CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)	Preferred Stock Series Seed preferred shares	Preferred Stock Series X Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Beginning balance at Dec. 31, 2021	$ 270		$ 691	$ 8,828,425	$ (18,938,249)	$ (10,108,863)
Beginning balance (in shares) at Dec. 31, 2021	2,696,439		6,913,492
Increase (Decrease) in Stockholders' Equity (Deficit)
Stock-based compensation				181,194		181,194
Net loss					1,863,462	1,863,462
Ending balance at Mar. 31, 2022	$ 270		$ 691	9,009,619	(17,074,787)	(8,064,207)
Ending balance (in shares) at Mar. 31, 2022	2,696,439		6,913,492
Beginning balance at Dec. 31, 2022		$ 5	$ 1,204	33,847,607	(33,740,016)	108,800
Beginning balance (in shares) at Dec. 31, 2022		45,567	12,035,592
Increase (Decrease) in Stockholders' Equity (Deficit)
Reclassification of shares settled liability to equity			$ 2	126,447		126,449
Reclassification of shares settled liability to equity (in shares)			23,808
Issuance of common stock in connection with equity purchase agreement			$ 120	2,804,880		2,805,000
Issuance of common stock in connection with equity purchase agreement (in shares)			1,200,000
Issuance of common stock warrants in connection with notes payable, net of fees				1,155,643		1,155,643
Stock-based compensation			$ 66	2,170,556		2,170,622
Stock-based compensation (in shares)			660,834
Net loss					(3,833,747)	(3,833,747)
Ending balance at Mar. 31, 2023		$ 5	$ 1,392	$ 40,105,133	$ (37,573,763)	$ 2,532,767
Ending balance (in shares) at Mar. 31, 2023		45,567	13,920,234